Kilitch Drugs (India) logo

Kilitch Drugs (India) share news and announcements

NSE: KILITCHBSE: 524500Pharmaceuticals & BiotechnologySmall Cap

Last close ₹202.24up ₹0.13 (0.06%)BSE ₹203.50

Share price at the NSE close on 23 Oct 2026. Previous close ₹202.11.

52-week range of traded prices to 23 Oct 2026
₹117.25Low, 30 Mar 2026₹267.90High, 7 Oct 2026
Market cap
₹707 Cr1,776th largest listed
P/E
23.5
P/B
2.5
Dividend yield
Nonein the last 12 months
ROE
12.5%
ROCE
8.9%
Debt to equity
0.32
Volume, NSE
1,44,52347.0% delivered

Kilitch Drugs (India) share news and announcements

492 announcements, routine notices left out, newest first. Page 5 of 10.

  1. Feb 2021

  2. Dec 2020

  3. Nov 2020

  4. Oct 2020

  5. Sep 2020

  6. Aug 2020

  7. Jul 2020

  8. Jun 2020

  9. May 2020

  10. Apr 2020

  11. Feb 2020

  12. Jan 2020

  13. Dec 2019

    • 18 Dec · Legal

      Exchange had sought clarification from Kilitch Drugs (India) Limited with respect to announcement dated 09-Dec-2019, regarding " Kilitch Drugs (India) Limited has informed the Exchange regarding a press release dated December 09, 2019, titled "Kilitch Drugs to set-up second green field Project in Ethiopia at an investment of USD 5 mn".". The Company on REPLY_DATE has clarified as below: Dear Sir,Sub: Reply to the Clarification sought with respect to an announcement regarding a press release titled Kilitch Drugs to set-up second green field Project in Ethiopia at an investment of USD 5 Millions.With reference to your query by email dated 17th December, 2019 seeking clarification with respect to an announcement submitted to the Exchange dated Dec 09, 2019, regarding a press release titled Kilitch Drugs to set-up second green field Project in Ethiopia at an investment of USD 5 Millions, please be informed as under, 1. Existing Capacity:- We are putting up plant no. 1 at Ethiopia for Cephalosporin injection, the project is in final stage of the Completion and we shall commence the production in the first quarter of 2020-21. The Green Field Project plant no. 2 is for liquid injectables like Gentamicin, Diclofenac, etc. Hence there is no comparison as such between the two plants. Plant no. 1 is for powder injectables and plant no. 2 is for liquid injectables. 2. Existing Capacity Utilization:- We have not started the production in plant no. 1, hence the query of capacity utilization does not arise. 3.Proposed capacity addition:- Plant no. 1 and plant no. 2 are separate. Plant no. 1 is for powder injectables and plant no. 2 is for liquid injectables. 4. Period within which the proposed capacity is to be added:- Plant no. 2 shall be on commercial stream by 2021-22. 5. Mode of financing:- As of the day we will finance the project from our own sources and reserves & surplus.You are requested to take the same on your record.

    • 17 Dec · Legal

      Exchange has sought clarification from Kilitch Drugs (India) Limited with respect to announcement dated 09-Dec-2019 regarding a press release titled Kilitch Drugs to set-up second green field Project in Ethiopia at an investment of USD 5 mn.On basis of above the Company is required to clarify following:1. Existing capacity;2. Existing capacity utilization;3. Proposed capacity addition;4. Period within which the proposed capacity is to be added;5. Mode of financing;The response of the Company is awaited.

    • 12 Dec · Board meeting

      Board meeting held on December 12, 2019. (opens in a new tab)

    • 9 Dec · Board meeting

      To Consider and approve the proposal for investing in setting up of new green field project in Ethiopia (opens in a new tab)

    • 9 Dec · Business

      Press release dated December 09, 2019, titled "Kilitch Drugs to set-up second green field Project in Ethiopia at an investment of USD 5 mn". (opens in a new tab)

    • 3 Dec · Related Party Transactions

      Disclosure of Related Party Transaction pursuant to Regulation 23(9) of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 (opens in a new tab)

  14. Nov 2019

  15. Oct 2019